149 Views

CRT 2023

Evening Symposium: Equality, Diversity and Inclusion: Addressing Inequalities in Interventional Cardiology and Healthcare

Evening Symposium: Equality, Diversity and Inclusion | Addressing Inequalities in Interventional Cardiology and Healthcare - Supported Through an Educational Grant by Abbott, Boston Scientific Corporation and Medtronic

DISPARITIES IN CLINICAL TRIALS AND BEYOND

Sunday, February 26, 2023

7:51 PM – 9:05 PM ET

Moderator(s)

Joaquin E. Cigarroa, MD

Head of the Division of Cardiovascular Medicine
OHSU Knight Cardiovascular Institute
Portland, Oregon, United States

No relationships to disclose
Rebecca Torguson, MPH

Deputy Division Director
FDA
Washington, District of Columbia, United States

No relationships to disclose
Karol Watson, MD, PhD

Attending Cardiologist
Ronald Reagan UCLA Medical Center
David Geffen School of Medicine at UCLA
Redondo Beach, California, United States

Disclosure(s): Amarin: Consultant (Ongoing); Amgen: Consultant (Ongoing); Boehringer Ingelheim: Consultant (Ongoing); Novartis Pharmaceuticals: Consultant (Ongoing)
Kim Allan Williams, Sr., MD, MACC, FAHA, MASNC, FESC

Chair, Department of Medicine
University of Louisville
Louisville, Kentucky, United States

No relationships to disclose

Disclosure(s):

Karol Watson, MD, PhD: Amarin: Consultant (Ongoing); Amgen: Consultant (Ongoing); Boehringer Ingelheim: Consultant (Ongoing); Novartis Pharmaceuticals: Consultant (Ongoing)